%0 Journal Article
%A Obrecht-Sturm, Denise
%A Schömig, Lena
%A Mynarek, Martin
%A Bison, Brigitte
%A Schwarz, Rudolf
%A Pietsch, Torsten
%A Pfister, Stefan
%A Sill, Martin
%A Sturm, Dominik
%A Sahm, Felix
%A Kortmann, Rolf-Dieter
%A Gerber, Nicolas U
%A von Bueren, André O
%A Fleischhack, Gudrun
%A Schüller, Ulrich
%A Nussbaumer, Gunther
%A Benesch, Martin
%A Rutkowski, Stefan
%T Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment.
%J Neuro-Oncology
%V 26
%N 9
%@ 1522-8517
%C Oxford
%I Oxford Univ. Press
%M DKFZ-2024-00699
%P 1712-1722
%D 2024
%Z 2024 Sep 5;26(9):1712-1722
%X This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma.Data on 84 pediatric patients with medulloblastoma and persistent residual lesions on centrally reviewed MRI at the end of first-line therapy were analyzed.Twenty patients (23.8
%K MRI (Other)
%K children (Other)
%K medulloblastoma (Other)
%K persistent residual disease (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:38578306
%R 10.1093/neuonc/noae071
%U https://inrepo02.dkfz.de/record/289304